Kromek’s Capital Markets Day 2025

As a global leader in advanced imaging and CBRN (Chemical, Biological, Radiological, and Nuclear) detection technology, NETPark-based Kromek is committed to delivering best-in-class solutions that drive safer, healthier communities worldwide. With a proven track record of innovation and robust year-on-year growth, Kromek is targeting medium-term revenues exceeding £60 million and a 30% EBITDA margin, building on the momentum from our expanding partnerships and strong divisional performance in Advanced Imaging and CBRN Detection.

Find out more